Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,541 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.
Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. Becker C, et al. Among authors: huber s. Immunity. 2004 Oct;21(4):491-501. doi: 10.1016/j.immuni.2004.07.020. Immunity. 2004. PMID: 15485627 Free article.
TGF-beta and CD4+CD25+ regulatory T cells.
Huber S, Schramm C. Huber S, et al. Front Biosci. 2006 Jan 1;11:1014-23. doi: 10.2741/1859. Front Biosci. 2006. PMID: 16146793 Review.
Checks and balances: IL-23 in the intestine.
Huber S, Flavell RA. Huber S, et al. Immunity. 2010 Aug 27;33(2):150-2. doi: 10.1016/j.immuni.2010.08.005. Immunity. 2010. PMID: 20732638 Free PMC article.
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.
Huber S, Gagliani N, Esplugues E, O'Connor W Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA. Huber S, et al. Among authors: huber fj. Immunity. 2011 Apr 22;34(4):554-65. doi: 10.1016/j.immuni.2011.01.020. Immunity. 2011. PMID: 21511184 Free PMC article.
1,541 results